139 related articles for article (PubMed ID: 37541171)
1. The natural history of ductal carcinoma in situ (DCIS) in simulation models: A systematic review.
Poelhekken K; Lin Y; Greuter MJW; van der Vegt B; Dorrius M; de Bock GH
Breast; 2023 Oct; 71():74-81. PubMed ID: 37541171
[TBL] [Abstract][Full Text] [Related]
2. Modeling the natural history of ductal carcinoma in situ based on population data.
Chootipongchaivat S; van Ravesteyn NT; Li X; Huang H; Weedon-Fekjær H; Ryser MD; Weaver DL; Burnside ES; Heckman-Stoddard BM; de Koning HJ; Lee SJ
Breast Cancer Res; 2020 May; 22(1):53. PubMed ID: 32460821
[TBL] [Abstract][Full Text] [Related]
3. Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
Schultz S; Bartsch H; Sotlar K; Petat-Dutter K; Bonin M; Kahlert S; Harbeck N; Vogel U; Seeger H; Fehm T; Neubauer HJ
BMC Med Genomics; 2018 Sep; 11(1):80. PubMed ID: 30236106
[TBL] [Abstract][Full Text] [Related]
4. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
van Luijt PA; Heijnsdijk EA; Fracheboud J; Overbeek LI; Broeders MJ; Wesseling J; den Heeten GJ; de Koning HJ
Breast Cancer Res; 2016 May; 18(1):47. PubMed ID: 27160733
[TBL] [Abstract][Full Text] [Related]
5. Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches.
van Ravesteyn NT; van den Broek JJ; Li X; Weedon-Fekjær H; Schechter CB; Alagoz O; Huang X; Weaver DL; Burnside ES; Punglia RS; de Koning HJ; Lee SJ
Med Decis Making; 2018 Apr; 38(1_suppl):126S-139S. PubMed ID: 29554463
[TBL] [Abstract][Full Text] [Related]
6. Ductal Carcinoma In Situ - Quo Vadis?
Peltecu G
Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S5-S6. PubMed ID: 34967322
[TBL] [Abstract][Full Text] [Related]
7. PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.
Agahozo MC; Sieuwerts AM; Doebar SC; Verhoef EI; Beaufort CM; Ruigrok-Ritstier K; de Weerd V; Sleddens HFBM; Dinjens WNM; Martens JWM; van Deurzen CHM
Endocr Relat Cancer; 2019 May; 26(5):471-482. PubMed ID: 30844755
[TBL] [Abstract][Full Text] [Related]
8. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
Sanders ME; Schuyler PA; Dupont WD; Page DL
Cancer; 2005 Jun; 103(12):2481-4. PubMed ID: 15884091
[TBL] [Abstract][Full Text] [Related]
9. [A systematic review of international simulation models on the natural history of breast cancer: current understanding and challenges for Chinese-population-specific model development].
Ma HM; Wang L; Shi JF; Ying JM; Zhu J; Chen LL; Yue XP; Gong JY; Li X; Wang JL; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Oct; 38(10):1419-1425. PubMed ID: 29060992
[No Abstract] [Full Text] [Related]
10. The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women's characteristics: is it the same?
Théberge I; Vandal N; Guertin MH; Perron L
Breast Cancer Res Treat; 2019 Apr; 174(2):525-535. PubMed ID: 30564969
[TBL] [Abstract][Full Text] [Related]
11. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Groen EJ; Elshof LE; Visser LL; Rutgers EJT; Winter-Warnars HAO; Lips EH; Wesseling J
Breast; 2017 Feb; 31():274-283. PubMed ID: 27671693
[TBL] [Abstract][Full Text] [Related]
12. Estimating the natural progression of non-invasive ductal carcinoma in situ breast cancer lesions using screening data.
Weedon-Fekjær H; Li X; Lee S
J Med Screen; 2021 Sep; 28(3):302-310. PubMed ID: 32854582
[TBL] [Abstract][Full Text] [Related]
13. Progression of ductal carcinoma in situ to invasive breast cancer: comparative genomic sequencing.
Doebar SC; Krol NM; van Marion R; Brouwer RWW; van Ijcken WFJ; Martens JM; Dinjens WNM; van Deurzen CHM
Virchows Arch; 2019 Feb; 474(2):247-251. PubMed ID: 30284611
[TBL] [Abstract][Full Text] [Related]
14. The natural history of ductal carcinoma in situ of the breast: a review.
Erbas B; Provenzano E; Armes J; Gertig D
Breast Cancer Res Treat; 2006 May; 97(2):135-44. PubMed ID: 16319971
[TBL] [Abstract][Full Text] [Related]
15. Characterizing the impact of 25 years of DCIS treatment.
Ozanne EM; Shieh Y; Barnes J; Bouzan C; Hwang ES; Esserman LJ
Breast Cancer Res Treat; 2011 Aug; 129(1):165-73. PubMed ID: 21390494
[TBL] [Abstract][Full Text] [Related]
16. Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
Soon PS; Provan PJ; Kim E; Pathmanathan N; Graham D; Clarke CL; Balleine RL
Clin Exp Metastasis; 2018 Feb; 35(1-2):3-13. PubMed ID: 29214365
[TBL] [Abstract][Full Text] [Related]
17. Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study.
Doebar SC; van den Broek EC; Koppert LB; Jager A; Baaijens MHA; Obdeijn IAM; van Deurzen CHM
Breast Cancer Res Treat; 2016 Jul; 158(1):179-187. PubMed ID: 27318854
[TBL] [Abstract][Full Text] [Related]
18. Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.
Muggerud AA; Hallett M; Johnsen H; Kleivi K; Zhou W; Tahmasebpoor S; Amini RM; Botling J; Børresen-Dale AL; Sørlie T; Wärnberg F
Mol Oncol; 2010 Aug; 4(4):357-68. PubMed ID: 20663721
[TBL] [Abstract][Full Text] [Related]
19. Should low-risk DCIS lose the cancer label? An evidence review.
Ma T; Semsarian CR; Barratt A; Parker L; Pathmanathan N; Nickel B; Bell KJL
Breast Cancer Res Treat; 2023 Jun; 199(3):415-433. PubMed ID: 37074481
[TBL] [Abstract][Full Text] [Related]
20. Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.
Langhans L; Jensen MB; Talman MM; Vejborg I; Kroman N; Tvedskov TF
JAMA Surg; 2017 Apr; 152(4):378-384. PubMed ID: 28002557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]